TCI Wealth Advisors’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
DM
SCM
GIM
TCI Wealth Advisors's ORGO Position: Q1 2022 in Review
TCI Wealth Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 422 shares — an estimated $4K sold.
TCI Wealth Advisors first reported a position in ORGO in Q3 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.
- TCI Wealth Advisors reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
- TCI Wealth Advisors sold 422 Organogenesis Holdings shares in Q1 2022, an estimated $4K.
- TCI Wealth Advisors first reported a position in Organogenesis Holdings in Q3 2019 and held it in 3 quarters.
- TCI Wealth Advisors's Organogenesis Holdings position peaked at $4K in Q4 2021.
- 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.
Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.